Nigeria, alongside seven other African countries, has embarked on a five-year research initiative to develop an effective HIV vaccine.
The project, funded by the United States Agency for International Development (USAID), is conducted in collaboration with the 'Bringing Innovation to Clinical and
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
